News

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...
Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage. When Kelvin Chan ...
TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...
Agents that target NaV1.8, a voltage-gated sodium channel, are showing promise. The FDA approved one of them, Journavx ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...
Cost is a barrier to care for chronic and rare diseases, so financial assistance is way to lower that barrier and help people ...
Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.
At this year’s Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive spoke with John Beardsley, senior ...
A growing and more diverse pipeline means that there is a greater need for digital innovations, which can address ...
The new research center at the University of Michigan and Oregon Health & Science University intends to develop a clinical ...